Peptidomic Approaches to Study Proteolytic Activity
互联网
- Abstract
- Table of Contents
- Materials
- Figures
- Literature Cited
Abstract
Peptidomics, the analysis of the peptide content of cells or tissues, can be used to study proteases in several ways. First, nearly all of the peptides detected in cells and tissues are proteolytic fragments of proteins. Analysis of the peptides therefore provides information regarding the proteolytic activities that occurred to generate the observed peptides. The use of quantitative peptidomic approaches allows the comparison of relative peptide levels in two or more different samples, which enables studies examining the consequences of increasing proteolytic activity (by enzyme activation or overexpression) or reducing proteolytic activity (by inhibition, knock down, or knock out). Quantitative peptidomics can also be used to directly test the cleavage specificity of purified proteases. For this, peptides are purified from the tissue or cell line of interest, incubated in the presence of various amounts of protease or in the absence of protease, and then analyzed by the quantitative peptidomics approach. This reveals which peptides are preferred substrates, which are products, and which are not cleaved. Collectively, these studies complement conventional approaches to study proteolytic activity and allow for a more complete understanding of an enzyme's substrate specificity. This unit describes the use of quantitative peptidomics in the analysis of the biological peptidome as well as in the in vitro analysis of peptidase activity. Curr. Protoc. Protein Sci. 65:18.13.1?18.13.12. © 2011 by John Wiley & Sons, Inc.
Keywords: proteomics; protease; mass spectrometry
Table of Contents
- Introduction
- Basic Protocol 1: Preparation and Analysis of Peptides by LC/MS
- Basic Protocol 2: Peptidomic Analysis of LC/MS Data
- Commentary
- Literature Cited
- Figures
Materials
Basic Protocol 1: Preparation and Analysis of Peptides by LC/MS
Materials
|
Figures
-
Figure 18.13.1 Method of labeling peptides with TMAB tags. (A ) The structure of the TMAB tags is shown. The N ‐hydroxysuccinimide (NHS) moiety is replaced by the N‐terminal or lysine side chain amines upon reaction with peptides. Five different isotopic forms of the label can be made containing different numbers of hydrogen, deuterium, 12 C, or 13 C in the methyl (Me) groups. (B ) To identify peptides and compare their levels among multiple tissues or treatments, peptides are extracted from tissues or cells and labeled directly with isotopic TMAB reagents. These peptides are then pooled and analyzed by LC/MS. (C ) To directly test the ability of proteases to cleave a variety of peptides, the peptides are first extracted from an appropriate biological sample (such as a tissue or cell population) and aliquots are digested with different amounts of a proteolytic enzyme (CONC 1‐4). The digests are differentially labeled with TMAB reagents, pooled, and analyzed by LC/MS. View Image -
Figure 18.13.2 Representative peptide substrates and products identified by quantitative peptidomics upon incubation with a peptidase. Peptides were extracted from mouse brain, digested with different amounts of purified carboxypeptidase A6, labeled with isotopic TMAB tags as indicated, and analyzed by LC‐MS/MS. Examples of representative data are shown for (A ) good substrates, (B ) weak substrates, (C ) non‐substrates, and (D ) products. Many additional substrates and products were detected in this analysis (Lyons and Fricker, ). View Image
Videos
Literature Cited
Literature Cited | |
Berezniuk, I., Sironi, J., Callaway, M.B., Castro, L.M., Hirata, I.Y., Ferro, E.S., and Fricker, L.D. 2010. CCP1/Nna1 functions in protein turnover in mouse brain: Implications for cell death in Purkinje cell degeneration mice. FASEB J. 24:1813‐1823. | |
Berti, D.A., Morano, C., Russo, L.C., Castro, L.M., Cunha, F.M., Zhang, X., Sironi, J., Klitzke, C.F., Ferro, E.S., and Fricker, L.D. 2009. Analysis of intracellular substrates and products of thimet oligopeptidase (EC 3.4.24.15) in human embryonic kidney 293 cells. J. Biol. Chem. 284:14105‐14116. | |
Che, F.Y. and Fricker, L.D. 2005. Quantitative peptidomics of mouse pituitary: Comparison of different stable isotopic tags. J. Mass Spectrom. 40:238‐249. | |
Ferro, E.S., Hyslop, S., and Camargo, A.C. 2004. Intracellullar peptides as putative natural regulators of protein interactions. J. Neurochem. 91:769‐777. | |
Fricker, L.D. 2010. Analysis of mouse brain peptides using mass spectrometry‐based peptidomics: Implications for novel functions ranging from non‐classical neuropeptides to microproteins. Mol. Biosyst. 6:1355‐1365. | |
Fricker, L.D., Lim, J., Pan, H., and Che, F.Y. 2006. Peptidomics: Identification and quantification of endogenous peptides in neuroendocrine tissues. Mass Spectrom. Rev. 25:327‐344. | |
Gelman, J.S., Sironi, J., Castro, L.M., Ferro, E.S., and Fricker, L.D. 2010. Hemopressins and other hemoglobin‐derived peptides in mouse brain: Comparison between brain, blood, and heart peptidome and regulation in Cpefat/fat mice. J. Neurochem. 113:871‐880. | |
Gelman, J.S., Wardman, J.H., Bhat, V.B., Gozzo, F.C., and Fricker, L.D. In Press. Quantitative peptidomics to measure neuropeptide levels in animal models relevant to psychiatric disorders. In Psychiatric Disorders: Methods and Protocols (F. Kobeissy, ed.). Humana Press. | |
Julka, S. and Regnier, F. 2004. Quantification in proteomics through stable isotope coding: A review. J. Proteome Res. 3:350‐363. | |
Lyons, P.J. and Fricker, L.D. 2010. Substrate specificity of human carboxypeptidase A6. J. Biol. Chem. 285:38234‐38242. | |
Mahrus, S., Trinidad, J.C., Barkan, D.T., Sali, A., Burlingame, A.L., and Wells, J.A. 2008. Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell 134:866‐876. | |
Morano, C., Zhang, X., and Fricker, L.D. 2008. Multiple isotopic labels for quantitative mass spectrometry. Anal. Chem. 80:9298‐9309. | |
Svensson, M., Skold, K., Svenningsson, P., and Andren, P.E. 2003. Peptidomics‐based discovery of novel neuropeptides. J. Proteome Res. 2:213‐219. | |
Tanco, S., Zhang, X., Morano, C., Aviles, F.X., Lorenzo, J., and Fricker, L.D. 2010. Characterization of the substrate specificity of human carboxypeptidase A4 and implications for a role in extracellular peptide processing. J. Biol. Chem. 285:18385‐18396. | |
Wardman, J.H., Zhang, X., Gagnon, S., Castro, L.M., Zhu, X., Steiner, D.F., Day, R., and Fricker, L.D. 2010. Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics. J. Neurochem. 114:215‐225. | |
Zhang, R., Sioma, C.S., Thompson, R.A., Xiong, L., and Regnier, F.E. 2002. Controlling deuterium isotope effects in comparative proteomics. Anal. Chem. 74:3662‐3669. | |
Zhang, X., Pan, H., Peng, B., Steiner, D.F., Pintar, J.E., and Fricker, L.D. 2010. Neuropeptidomic analysis establishes a major role for prohormone convertase‐2 in neuropeptide biosynthesis. J. Neurochem. 112:1168‐1179. |